impact factor, citescore
logo
 

Full Papers

 

A link between CD8+CD27-CD28- T cells expressing chemerin chemokine-like receptor 1 and rheumatoid arthritis


1, 2, 3, 4, 5, 6, 7

 

  1. Department of Microbiology, Ajou University School of Medicine, Suwon; and Department of Biomedical Sciences, The Graduate School, Ajou University, Suwon, Republic of Korea.
  2. Department of Rheumatology, Ajou University School of Medicine, Suwon, Republic of Korea.
  3. Department of Microbiology, Ajou University School of Medicine, Suwon, Republic of Korea.
  4. Department of Rheumatology, Ajou University School of Medicine, Suwon, Republic of Korea.
  5. Department of Microbiology, Ajou University School of Medicine, Suwon; and Department of Biomedical Sciences, The Graduate School, Ajou University, Suwon, Republic of Korea.
  6. Department of Microbiology, Ajou University School of Medicine, Suwon; and Department of Biomedical Sciences, The Graduate School, Ajou University, Suwon, Republic of Korea.
  7. Department of Microbiology, Ajou University School of Medicine, Suwon; and Department of Biomedical Sciences, The Graduate School, Ajou University, Suwon, Republic of Korea. sinsun@ajou.ac.kr

CER15869
2023 Vol.41, N°5
PI 1105, PF 1113
Full Papers

purchase article

PMID: 36200942 [PubMed]

Received: 22/05/2022
Accepted : 01/09/2022
In Press: 04/10/2022
Published: 03/05/2023

Abstract

OBJECTIVES:
Transcription of the chemerin chemokine-like receptor 1 (CMKLR1) has been observed in T cell subsets, but its role in T cells has not been well studied. As previously reported, the levels of its ligand, chemerin, are increased in the plasma and synovial fluid of patients with rheumatoid arthritis (RA); hence, we aimed to explore the expression and role of CMKLR1 in the T cells of these patients.
METHODS:
Peripheral blood and synovial fluid from patients with RA or osteoarthritis and healthy individuals were collected to analyse the frequency of CD27-CD28- T cells and the expression of CMKLR1 and TNF-α by flow cytometry. Chemotaxis of T cells was assessed using a Transwell migration assay. Chemerin levels were measured using an enzyme-linked immunosorbent assay.
RESULTS:
CMKLR1 was preferentially expressed in CD27-CD28- T cell subsets. Its surface levels were reduced by stimulation with anti-CD3 antibody or chemerin. We found a correlation between CMKLR1+CD8+CD27-CD28- T cell frequency and disease activity score 28 of RA. Chemerin treatment up-regulated but CMKLR1 inhibitor treatment down-regulated TNF-α expression in CD8+CD27-CD28- T cells, half of which express CMKLR1 on average. Moreover, chemerin induced migration of these cells. Analysis of blood and synovial fluid samples of RA showed a reduction of CMKLR1+CD27-CD28- T cell levels in the synovial fluid, with a few exceptions.
CONCLUSIONS:
Our results suggest that CMKLR1 expression in T cells may be involved in RA pathogenesis through modulation of TNF-α expression and cell migration.

DOI: https://doi.org/10.55563/clinexprheumatol/52v1bb

Rheumatology Article

Rheumatology Addendum